Clinical Trial Update: Effect of an H1 Receptor Antagonist on Exercise Performance in Hypoxia [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effect of an H1 receptor antagonist on exercise performance in hypoxia/altitude conditions has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Altitude
• Hypoxia

Drugs mentioned

• H1 receptor antagonist

Snippet

Sponsor: Indiana University | Conditions: Hypoxia, Altitude | Phase 4 | Status: COMPLETED | Results posted: 2020-06-16